HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bloomgarden, Z. T. Search for Related Content PubMed PubMed Citation Articles by Bloomgarden, Z. T. Social Bookmarking                What's this?

Diabetic Nephropathy

Abbreviations: ARB, angiotensin II receptor blocker • AT1, angiotensin II type 1 • CKD, chronic kidney disease • CVD, cardiovascular disease • GBM, glomerular basement membrane • GFR, glomerular filtration rate • IDNT, Irbesartan Diabetic Nephropathy Trial • NF, nuclear factor • oxLDL, oxidized LDL • PKC, protein kinase C • TGF, transforming growth factor • VEGF, vascular endothelial growth factor

The first 300 words of the full text of this article appear below.

This is the sixth in a series of articles on presentations at the American Diabetes Association Annual Meeting, Orlando, Florida, 4–8 June 2004.

Mechanisms

At a symposium on the development of diabetic nephropathy, Erwin Böttinger (New York, NY) discussed the molecular pathology of diabetic nephropathy in mice and men, referring to the growing problems of chronic kidney disease (CKD) due to diabetes. The U.S. prevalence of CKD is predicted to increase from 340,000 persons in 2000 to 660,000 in 2010, with annual cost increasing from 15 to 30 billion dollars. Diabetes differs from other causes of CKD in its predictability, with well-defined functional progression from hyperfiltration to micro- to macroalbuminuria to renal failure. The morphologic findings of glomerular basement membrane (GBM) thickening, mesangial expansion, arteriolar hyalinosis, glomerulosclerosis, and tubulo-interstitial fibrosis are well recognized. Böttinger termed the cellular substrate of diabetic nephropathy, however, "much less clear," with podocyte depletion, which appears to be a reproducible early finding, appearing to be crucial to disease pathogenesis. Podocytes are glomerular epithelial cells essential for glomerular structure and function, surrounding glomerular capillaries and forming foot processes contributing to the filtration barrier and providing structural stabilization. Podocyte depletion in human diabetic nephropathy may be a genetic trait (independent of diabetes), may be caused by detachment from the basement membrane due to the disease process, or may be caused by apoptosis or necrosis.

In mouse models of type 1 (streptozotocin [STZ]) and type 2 (db/db) diabetes, hyperglycemia predictably leads to development of albuminuria. Podocyte loss is seen after onset of hyperglycemia and precedes the onset of albuminuria, with podocyte apoptosis coinciding with the onset of hyperglycemia, again preceding albuminuria. Endocapillary apoptosis is not observed in these models. In cell culture, there is a dose response between ambient glucose and the degree of podocyte apoptosis, suggesting a . . . [Full Text of this Article]

Epidemiologic trends

ACE inhibitor versus ARB

Clinical studies

Pathogenesis.
Anemia.
Therapeutic approaches.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. Maffi, F. Bertuzzi, F. De Taddeo, P. Magistretti, R. Nano, P. Fiorina, A. Caumo, P. Pozzi, C. Socci, M. Venturini, et al. Kidney Function After Islet Transplant Alone in Type 1 Diabetes: Impact of immunosuppressive therapy on progression of diabetic nephropathy Diabetes Care, May 1, 2007; 30(5): 1150 - 1155. [Abstract] [Full Text] [PDF]

				A. P. W. Johnston, J. E. Campbell, J. G. Found, M. C. Riddell, and T. J. Hawke Streptozotocin induces G2 arrest in skeletal muscle myoblasts and impairs muscle growth in vivo Am J Physiol Cell Physiol, March 1, 2007; 292(3): C1033 - C1040. [Abstract] [Full Text] [PDF]

				Y. Luo, M. Chen, Q. Wen, M. Zhao, B. Zhang, X. Li, F. Wang, Q. Huang, C. Yao, T. Jiang, et al. Rapid and Simultaneous Quantification of 4 Urinary Proteins by Piezoelectric Quartz Crystal Microbalance Immunosensor Array Clin. Chem., December 1, 2006; 52(12): 2273 - 2280. [Abstract] [Full Text] [PDF]

				Y. Kanetsuna, K. Hirano, M. Nagata, M. A. Gannon, K. Takahashi, R. C. Harris, M. D. Breyer, and T. Takahashi Characterization of diabetic nephropathy in a transgenic model of hypoinsulinemic diabetes Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1315 - F1322. [Abstract] [Full Text] [PDF]